PRODUCTION OF STABLE ISOTOPICALLY LABELLED GLYCEROL

Information

  • Research Project
  • 3496023
  • ApplicationId
    3496023
  • Core Project Number
    R43DK043174
  • Full Project Number
    1R43DK043174-01
  • Serial Number
    43174
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1990 - 34 years ago
  • Project End Date
    2/28/1991 - 34 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1990 - 34 years ago
  • Budget End Date
    2/28/1991 - 34 years ago
  • Fiscal Year
    1990
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/16/1990 - 34 years ago

PRODUCTION OF STABLE ISOTOPICALLY LABELLED GLYCEROL

DESCRIPTION: (Adapted from the applicant's abstract) The presence of enriched stable isotope contents in proteins, coupled with sophisticated 2D and 3D nuclear magnetic resonance techniques enables a rapid and easy determination of amino acid sequence and protein structure. Glycerol is often used as the sole carbon source for the growth of genetically modified bacteria that overproduce particular proteins, and in the presence of labelled glycerol the proteins will be labelled. Deuterated glycerol and l3C-glycerol are commercially available, but high cost and uncertain availability limit their widespread usage. The goal of this research is to study the production and determine the economic feasibility of producing l3C- and 2H-glycerol. They propose to produce isotopically labelled glycerol biologically from the photosynthetic microalgae Dunaliella salina, an organism widely reported to produce up to 50 percent of its biomass as glycerol. For the production of deuterated glycerol, D. salina will be grown in D2-0 (heavy water). They also plan to chemically synthesize economics of chemical synthesis to those of biological production. Success in achieving this goal will lay the groundwork for the development of stable isotopically labelled compounds that will be vital for the elucidation of protein structures.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    MARTEK BIOSCIENCE CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    COLUMBIA
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    21045
  • Organization District
    UNITED STATES